Cancer Research Versailles No Abst Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 6185-6191, December 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, F.
Right arrow Articles by Spiegel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, F.
Right arrow Articles by Spiegel, S.
[Cancer Research 59, 6185-6191, December 15, 1999]
© 1999 American Association for Cancer Research

Experimental Therapeutics

Sphingosine-1-phosphate Inhibits Motility of Human Breast Cancer Cells Independently of Cell Surface Receptors1

Fang Wang, James R. Van Brocklyn, Lisa Edsall, Victor E. Nava and Sarah Spiegel2

Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007

Exogenous sphingosine-1-phosphate (SPP) inhibits chemotactic motility of several transformed cell lines. We have found that SPP at high micromolar concentrations decreased chemotaxis of estrogen-independent (MDA-MB-231 and BT 549) and estrogen-dependent (MCF-7 and ZR-75-1) human breast cancer cells. Because SPP has been implicated as a lipid-signaling molecule with novel dual intra- and intercellular actions, it was of interest to determine whether the effect of SPP on chemotactic motility of human breast cancer cells is mediated intracellularly or through the recently identified endothelial differentiation gene (EDG) family of G protein-coupled SPP receptors. There was no detectable specific binding of [32P]SPP to MDA-MB-231 or MCF-7 cells; however, reverse transcription-PCR analysis revealed that both MDA-MB-231 and MCF-7 cells expressed moderate levels of EDG-3, neither expressed EDG-1, and EDG-5 mRNA was expressed in MCF-7 but not in MDA-MB-231 cells. In contrast to SPP, sphinganine-1-phosphate, which binds to and signals through SPP receptors EDG-1, EDG-3, and EDG-5, had no effect on chemotactic motility of MDA-MB-231 or MCF-7 cells. To further discriminate between intracellular and receptor-mediated actions of SPP, we used caged SPP, a photolyzable derivative of SPP that elevates intracellular levels of SPP after illumination. Caged SPP inhibited chemotactic motility of MDA-MB-231 cells only upon UV irradiation. In addition, in MCF-7 cells, overexpression of sphingosine kinase, the enzyme that produces SPP, inhibited chemotactic motility compared with vector-transfected cells and markedly increased cellular SPP levels in the absence of detectable secretion. Our results suggest that the inhibitory effect of SPP on chemotactic motility of human breast cancer cells is likely mediated through intracellular actions of SPP rather than through cell surface receptors.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. J. Kusner, C. R. Thompson, N. A. Melrose, S. M. Pitson, L. M. Obeid, and S. S. Iyer
The Localization and Activity of Sphingosine Kinase 1 Are Coordinately Regulated with Actin Cytoskeletal Dynamics in Macrophages
J. Biol. Chem., August 10, 2007; 282(32): 23147 - 23162.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
O. Sukocheva, C. Wadham, A. Holmes, N. Albanese, E. Verrier, F. Feng, A. Bernal, C. K. Derian, A. Ullrich, M. A. Vadas, et al.
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1
J. Cell Biol., April 24, 2006; 173(2): 301 - 310.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. C. Hait, S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel
Role of Sphingosine Kinase 2 in Cell Migration toward Epidermal Growth Factor
J. Biol. Chem., August 19, 2005; 280(33): 29462 - 29469.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. S. Jolly, M. Bektas, K. R. Watterson, H. Sankala, S. G. Payne, S. Milstien, and S. Spiegel
Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors
Blood, June 15, 2005; 105(12): 4736 - 4742.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
M. Bektas, S. G. Payne, H. Liu, S. Goparaju, S. Milstien, and S. Spiegel
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells
J. Cell Biol., June 6, 2005; 169(5): 801 - 811.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Le Stunff, A. Mikami, P. Giussani, J. P Hobson, P. S. Jolly, S. Milstien, and S. Spiegel
Role of Sphingosine-1-phosphate Phosphatase 1 in Epidermal Growth Factor-induced Chemotaxis
J. Biol. Chem., August 13, 2004; 279(33): 34290 - 34297.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Olivera, H. M. Rosenfeldt, M. Bektas, F. Wang, I. Ishii, J. Chun, S. Milstien, and S. Spiegel
Sphingosine Kinase Type 1 Induces G12/13-mediated Stress Fiber Formation, yet Promotes Growth and Survival Independent of G Protein-coupled Receptors
J. Biol. Chem., November 21, 2003; 278(47): 46452 - 46460.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
O. A. Sukocheva, L. Wang, N. Albanese, S. M. Pitson, M. A. Vadas, and P. Xia
Sphingosine Kinase Transmits Estrogen Signaling in Human Breast Cancer Cells
Mol. Endocrinol., October 1, 2003; 17(10): 2002 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Clair, J. Aoki, E. Koh, R. W. Bandle, S. W. Nam, M. M. Ptaszynska, G. B. Mills, E. Schiffmann, L. A. Liotta, and M. L. Stracke
Autotaxin Hydrolyzes Sphingosylphosphorylcholine to Produce the Regulator of Migration, Sphingosine-1-Phosphate
Cancer Res., September 1, 2003; 63(17): 5446 - 5453.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Arikawa, N. Takuwa, H. Yamaguchi, N. Sugimoto, J. Kitayama, H. Nagawa, K. Takehara, and Y. Takuwa
Ligand-dependent Inhibition of B16 Melanoma Cell Migration and Invasion via Endogenous S1P2 G Protein-coupled Receptor: REQUIREMENT OF INHIBITION OF CELLULAR RAC ACTIVITY
J. Biol. Chem., August 29, 2003; 278(35): 32841 - 32851.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
G. Li, C. Foote, S. Alexander, and H. Alexander
Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum
Development, September 15, 2001; 128(18): 3473 - 3483.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
Y. Xu, Y.-j. Xiao, L. M. Baudhuin, and B. M. Schwartz
The Role and Clinical Applications of Bioactive Lysolipids in Ovarian Cancer
Reproductive Sciences, January 1, 2001; 8(1): 1 - 13.
[Abstract] [PDF]

Home page
 Mol. Cell. Biol.Home page
H. Okamoto, N. Takuwa, T. Yokomizo, N. Sugimoto, S. Sakurada, H. Shigematsu, and Y. Takuwa
Inhibitory Regulation of Rac Activation, Membrane Ruffling, and Cell Migration by the G Protein-Coupled Sphingosine-1-Phosphate Receptor EDG5 but Not EDG1 or EDG3
Mol. Cell. Biol., December 15, 2000; 20(24): 9247 - 9261.
[Abstract] [Full Text]

Home page
 GeneticsHome page
S. Kim, H. Fyrst, and J. Saba
Accumulation of Phosphorylated Sphingoid Long Chain Bases Results in Cell Growth Inhibition in Saccharomyces cerevisiae
Genetics, December 1, 2000; 156(4): 1519 - 1529.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
J. H. Paik, S.-s. Chae, M.-J. Lee, S. Thangada, and T. Hla
Sphingosine 1-Phosphate-induced Endothelial Cell Migration Requires the Expression of EDG-1 and EDG-3 Receptors and Rho-dependent Activation of alpha vbeta 3- and beta 1-containing Integrins
J. Biol. Chem., April 6, 2001; 276(15): 11830 - 11837.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.